Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
35.47
+1.34 (3.93%)
Jun 26, 2026, 4:00 PM EDT - Market closed
HRMY Market Cap
HRMY has a market cap or net worth of $2.05 billion as of June 29, 2026. Its market cap has increased by 1.76% in one year.
Market Cap
2.05B
Enterprise Value
1.58B
1-Year Change
1.76%
Ranking
Category
Stock Price
$35.47
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $2.05B, an increase of 345.40%. That is a compound annual growth rate of 29.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 2.05B | -4.72% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocular Therapeutix | 2.15B |
| Nektar Therapeutics | 2.15B |
| Palvella Therapeutics | 2.13B |
| Generate Biomedicines | 2.11B |
| Kardigan | 2.11B |
| Precigen | 2.09B |
| ADMA Biologics | 2.03B |
| Zai Lab | 2.02B |